Retinitis Pigmentosa Clinical Trial
Official title:
Study of the Correlation Between Macular Thickness Analyzed by Optical Coherence Tomography and the Visual Functions in Retinitis Pigmemtosa
Purpose: To study the associations between visual functions and the retinal tomography
detected by optical coherence tomography (OCT) in patients with retinitis pigmentosa (RP).
Study design: retrospective, non-randomized and non-comparable study Material: Medical
recordings of the RP patients who visited the Out-Patient Department of Ophthalmology in
NTUH during June, 2003 to June, 2008.
Methods: By reviewing charts of the RP patients, the investigators will categorize RP
patients into different types according to the loci of the pathological change in their
retina evaluated by opththaomoscopy. And the investigators will collect the data of their
visual functions including visual acuity, visual field, Arden ratio of electrooculography,
and color sense discrimination. Then, according to the OCT map, the investigators will
analyze the retinal thickness by dividing the macular area into foveal area, inner ring and
outer ring. Finally, the investigators will analyze the relationships between visual
functions and retinal thickness in different macular areas in different types of RP
patients.
Anticipated results: The investigators expect that retinal tomographies may different among
different types of RP. And the retinal tomographic change may correspond to the change of a
certain kind of visual function. Hence, according to the thickness of a specific area in
macula, the investigators may anticipate that some visual dysfunction may exist.
The diagnosis of RP was according to the typical clinical history of night blindness,
characteristically findings of "bone-spicule" change in the fundus, and varying degrees of
peripheral visual field constriction. According to the affected loci in the fundus, we
defined a typical type of RP as the retinal pathological change was around the banded area
outside the main vascular arcs, and a central variant of RP stood for those with
bone-spicule change appeared at the macula.[17] The exclusion criteria included eyes with
histories of trauma, intraocular laser treatment, intraocular surgery, presence of retinal
diseases, high degree of myopia with refraction more minus than -8.0 D or hyperopia with
refraction more than +5.0 D. Patients with systemic diseases that may affect retina like
diabetes or hypertension were also excluded.
Visual acuity was examined with a Snellen visual chart with a calibrated luminance. Then
according to the equation that Snellen VA equals to 1/MAR (MAR= minimal angle of
resolution), Snellen VA was converted into logMAR for statistics. For calculation, visual
acuity of hand motion was converted into 20/2000 and light perception was converted into
20/20000 of Snellen fraction. Visula field examination was evaluated using Goldmann kinetic
perimetry with varying sizes and illuminations of testing light spots. Then the degree of
the widest visual field isopter was recorded. EOG: is used to assess function of retinal
pigment epithelium. During dark adaptation, resting potential decreases slightly and reaches
a minimum ("dark trough"). When the light is on, the resting potential increases ("light
peak"). The ratio of light peak voltage versus dark trough voltage is known as the Arden
ratio. The EOG was performed with pupil dilated, first in the dark for 15 minutes, and then
in the light for 15 minutes and the Arden ratio for analysis was recorded.
Color sense discrimination test was evaluated using Farnsworth Munsell 100-Hue test (Munsell
FM 100, X-Rite, USA). Each patient arranged four trays of colored caps in hue order. There
is a predetermined sequence for each tray. The closer the patient's arrangement is to the
correct sequence, the better the patient's color sense discrimination. The
Farnsworth-Munsell 100-Hue Test Scoring Software was used to score the results of
Farnsworth-Munsell 100-Hue Test. The results are displayed in polar or linear format, and
the total error score was recorded for calculation.
OCT was performed with the ultimate commercial OCT units (OCT3, Carl Zeiss Meditec, Inc,
Dublin, CA) to measure the macular thickness under papillary dilatation by an experienced
examiner. The retinal thickness was calculated using OCT retinal mapping software (version
6.1 a), which measured thickness of nine divided macular regions after six scans with 6 mm
long centered on the patient's fixation point by means of an inner fixation target (Figure
1), and expressed as a color-coded map. Internal fixation was essentially chosen due to
better reproducibility. We defined the foveal area as the area centered at fixation with a
diameter of one millimeter, the inner ring as the area between circles with diameter of one
and three millimeters, and outer ring as the area between circles with diameter of three and
six millimeters (Figure 2).
We analyzed and compared the patients' characteristics, results of visual function tests and
macular tomography in these two groups of RP. Then we tried to find out if there were
correlations between macular tomography and visual function tests
;
Observational Model: Case-Only, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01432847 -
Cell Collection to Study Eye Diseases
|
||
Completed |
NCT04983914 -
Retrospective NIS to Evaluate the Patient Benefit of TES
|
||
Recruiting |
NCT03845218 -
Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures
|
||
Completed |
NCT00231010 -
Molecular Genetics of Retinal Degenerations
|
||
Active, not recruiting |
NCT04611503 -
PDE6A Gene Therapy for Retinitis Pigmentosa
|
Phase 1/Phase 2 | |
Completed |
NCT02909985 -
Visual Activity Evoked by Infrared in Humans After Dark Adaptation
|
N/A | |
Recruiting |
NCT01914913 -
Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa
|
Phase 1/Phase 2 | |
Completed |
NCT01949623 -
Biomarkers In Retinitis Pigmentosa (BIRP)
|
N/A | |
Completed |
NCT01835002 -
Transcorneal Electrical Stimulation - Multicenter Safety Study
|
N/A | |
Completed |
NCT00407602 -
Argus® II Retinal Stimulation System Feasibility Protocol
|
N/A | |
Completed |
NCT00515814 -
Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors
|
N/A | |
Completed |
NCT00100230 -
DHA and X-Linked Retinitis Pigmentosa
|
Phase 2 | |
Active, not recruiting |
NCT00378742 -
Repository for Inherited Eye Diseases
|
||
Terminated |
NCT05085964 -
An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa
|
Phase 2 | |
Recruiting |
NCT05805007 -
Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa
|
Early Phase 1 | |
Recruiting |
NCT06291935 -
Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene
|
Phase 1 | |
Recruiting |
NCT05909488 -
Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II
|
Phase 2/Phase 3 | |
Recruiting |
NCT03078309 -
The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients
|
Early Phase 1 | |
Completed |
NCT04238858 -
Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa
|
N/A | |
Active, not recruiting |
NCT01680510 -
The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil
|
Phase 1/Phase 2 |